BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nenna A, Nappi F, Larobina D, Verghi E, Chello M, Ambrosio L. Polymers and Nanoparticles for Statin Delivery: Current Use and Future Perspectives in Cardiovascular Disease. Polymers (Basel) 2021;13:711. [PMID: 33652927 DOI: 10.3390/polym13050711] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Márquez-sánchez AC, Sánchez-segura L, Lund G, Zaina S. Nanoparticle-Based Modification of the DNA Methylome: A Therapeutic Tool for Atherosclerosis? Cardiogenetics 2022;12:12-23. [DOI: 10.3390/cardiogenetics12010002] [Reference Citation Analysis]
2 Climent E, Benaiges D, Pedro-Botet J. Hydrophilic or Lipophilic Statins? Front Cardiovasc Med 2021;8:687585. [PMID: 34095267 DOI: 10.3389/fcvm.2021.687585] [Reference Citation Analysis]
3 Yusa SI. A New Year's Message 2022. Polymers (Basel) 2022;14:500. [PMID: 35160489 DOI: 10.3390/polym14030500] [Reference Citation Analysis]
4 Leal BH, Velasco B, Cambón A, Pardo A, Fernandez-vega J, Arellano L, Al-modlej A, Mosquera VX, Bouzas A, Prieto G, Barbosa S, Taboada P. Combined Therapeutics for Atherosclerosis Treatment Using Polymeric Nanovectors. Pharmaceutics 2022;14:258. [DOI: 10.3390/pharmaceutics14020258] [Reference Citation Analysis]
5 Xie L, Zhu G, Shang J, Chen X, Zhang C, Ji X, Zhang Q, Wei Y. An overview on the biological activity and anti-cancer mechanism of lovastatin. Cell Signal 2021;87:110122. [PMID: 34438015 DOI: 10.1016/j.cellsig.2021.110122] [Reference Citation Analysis]